Study S002496

Discontinuation One Week Recommendations for GLP-1 Receptor Agonists Prior to Esophagogastroduodenoscopy: A Randomized Controlled Trial.

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT07736911
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE3
Masking: DOUBLE
Status: RECRUITING
Enrollment: 140
Start: 2026-06-01
Primary completion: 2029-06-01
Lead sponsor: Fu Jen Catholic University Hospital
Conditions: GLP-1
Interventions: DRUG:GLP-1 Stop for 1 week; DRUG:GLP-1 non stop
Results posted: FALSE
Individual participant data sharing: NO

Registered primary outcomes

This scoring system is referred to as PEACE (Polprep: Effective Assessment of Cleanliness in Esophagogastroduodenoscopy) ["From enrollment to the end of treatment at least 30 days]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.